HEADER OXYGEN TRANSPORT 22-MAR-22 7UF7 TITLE CRYSTAL STRUCTURE OF LIGANDED HB WITH THE 5-HMF ANALOG, MMA503 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEMOGLOBIN SUBUNIT ALPHA; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: ALPHA-GLOBIN,HEMOGLOBIN ALPHA CHAIN; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: HEMOGLOBIN SUBUNIT BETA; COMPND 8 CHAIN: B, D; COMPND 9 SYNONYM: BETA-GLOBIN,HEMOGLOBIN BETA CHAIN; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HBA1, HBA2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: HBB; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS HEMOGLOBIN, 5-HMF, SICKLE CELL DISEASE, ANTISICKLING, OXYGEN KEYWDS 2 EQUILIBRIUM, AROMATIC ALDEHYDES, OXYGEN TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR A.K.DONKOR,F.N.MUSAYEV,M.K.SAFO REVDAT 2 18-OCT-23 7UF7 1 REMARK REVDAT 1 30-MAR-22 7UF7 0 JRNL AUTH M.E.EL-ARABY,A.M.OMAR,M.S.GHATGE,F.N.MUSAYEV,A.K.DONKOR, JRNL AUTH 2 S.D.PAREDES,O.ABDULMALIK,M.K.SAFO JRNL TITL IMPROVING THE ANTISICKLING ACTIVITY OF FURALDEHYDE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.13_2998 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.22 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 37732 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.161 REMARK 3 R VALUE (WORKING SET) : 0.157 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1882 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.2220 - 4.6960 0.99 2931 141 0.1608 0.1942 REMARK 3 2 4.6960 - 3.7301 1.00 2821 140 0.1321 0.1776 REMARK 3 3 3.7301 - 3.2594 1.00 2790 149 0.1413 0.1973 REMARK 3 4 3.2594 - 2.9617 1.00 2752 144 0.1620 0.2253 REMARK 3 5 2.9617 - 2.7496 1.00 2780 130 0.1622 0.2331 REMARK 3 6 2.7496 - 2.5876 1.00 2732 152 0.1727 0.2639 REMARK 3 7 2.5876 - 2.4581 1.00 2752 139 0.1676 0.2758 REMARK 3 8 2.4581 - 2.3512 1.00 2724 150 0.1626 0.2142 REMARK 3 9 2.3512 - 2.2607 1.00 2708 152 0.1611 0.2458 REMARK 3 10 2.2607 - 2.1827 1.00 2726 148 0.1630 0.2454 REMARK 3 11 2.1827 - 2.1145 1.00 2728 138 0.1629 0.2360 REMARK 3 12 2.1145 - 2.0541 1.00 2722 149 0.1733 0.2666 REMARK 3 13 2.0541 - 2.0000 1.00 2684 150 0.1881 0.2951 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.410 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.19 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.29 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4753 REMARK 3 ANGLE : 0.858 6522 REMARK 3 CHIRALITY : 0.048 704 REMARK 3 PLANARITY : 0.006 817 REMARK 3 DIHEDRAL : 12.647 2696 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7UF7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-MAR-22. REMARK 100 THE DEPOSITION ID IS D_1000264079. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-DEC-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5406 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : VARIMAX TM-VHF ARC)SEC CONFOCAL REMARK 200 OPTICAL SYSTEM REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER R 4M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSALISPRO 41.64.69A REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.32 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37792 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 28.222 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.04500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 30.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.22600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3IC0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30 MG/DL OF CO-LIGATED HB CRYSTALLIZED REMARK 280 USING 10-20% PEG 6000, 100 MM HEPES, PH 7.4, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.30700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.56100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.56000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.56100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.30700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.56000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11870 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -116.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 MET B 0 REMARK 465 MET C 0 REMARK 465 MET D 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 FE HEM D 201 C CMO D 202 1.93 REMARK 500 FE HEM A 201 C CMO A 202 1.93 REMARK 500 FE HEM B 201 C CMO B 202 1.94 REMARK 500 FE HEM C 201 C CMO C 202 1.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS B 77 50.64 -143.87 REMARK 500 ASP C 75 30.34 -147.75 REMARK 500 HIS D 77 53.20 -142.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 201 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 87 NE2 REMARK 620 2 HEM A 201 NA 87.9 REMARK 620 3 HEM A 201 NB 86.4 89.0 REMARK 620 4 HEM A 201 NC 86.5 174.3 89.4 REMARK 620 5 HEM A 201 ND 90.3 92.3 176.4 89.0 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 201 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 92 NE2 REMARK 620 2 HEM B 201 NA 89.8 REMARK 620 3 HEM B 201 NB 90.9 88.3 REMARK 620 4 HEM B 201 NC 83.6 173.2 90.1 REMARK 620 5 HEM B 201 ND 84.2 92.3 175.0 88.7 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM C 201 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS C 87 NE2 REMARK 620 2 HEM C 201 NA 84.4 REMARK 620 3 HEM C 201 NB 89.4 87.7 REMARK 620 4 HEM C 201 NC 92.7 175.0 88.2 REMARK 620 5 HEM C 201 ND 90.1 94.1 178.1 90.0 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM D 201 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 92 NE2 REMARK 620 2 HEM D 201 NA 90.5 REMARK 620 3 HEM D 201 NB 89.6 88.6 REMARK 620 4 HEM D 201 NC 83.7 173.5 88.5 REMARK 620 5 HEM D 201 ND 86.4 92.6 175.8 89.8 REMARK 620 N 1 2 3 4 DBREF 7UF7 A 0 141 UNP P69905 HBA_HUMAN 1 142 DBREF 7UF7 B 0 146 UNP P68871 HBB_HUMAN 1 147 DBREF 7UF7 C 0 141 UNP P69905 HBA_HUMAN 1 142 DBREF 7UF7 D 0 146 UNP P68871 HBB_HUMAN 1 147 SEQRES 1 A 142 MET VAL LEU SER PRO ALA ASP LYS THR ASN VAL LYS ALA SEQRES 2 A 142 ALA TRP GLY LYS VAL GLY ALA HIS ALA GLY GLU TYR GLY SEQRES 3 A 142 ALA GLU ALA LEU GLU ARG MET PHE LEU SER PHE PRO THR SEQRES 4 A 142 THR LYS THR TYR PHE PRO HIS PHE ASP LEU SER HIS GLY SEQRES 5 A 142 SER ALA GLN VAL LYS GLY HIS GLY LYS LYS VAL ALA ASP SEQRES 6 A 142 ALA LEU THR ASN ALA VAL ALA HIS VAL ASP ASP MET PRO SEQRES 7 A 142 ASN ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS SEQRES 8 A 142 LEU ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS SEQRES 9 A 142 CYS LEU LEU VAL THR LEU ALA ALA HIS LEU PRO ALA GLU SEQRES 10 A 142 PHE THR PRO ALA VAL HIS ALA SER LEU ASP LYS PHE LEU SEQRES 11 A 142 ALA SER VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 B 147 MET VAL HIS LEU THR PRO GLU GLU LYS SER ALA VAL THR SEQRES 2 B 147 ALA LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY SEQRES 3 B 147 GLU ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR SEQRES 4 B 147 GLN ARG PHE PHE GLU SER PHE GLY ASP LEU SER THR PRO SEQRES 5 B 147 ASP ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY SEQRES 6 B 147 LYS LYS VAL LEU GLY ALA PHE SER ASP GLY LEU ALA HIS SEQRES 7 B 147 LEU ASP ASN LEU LYS GLY THR PHE ALA THR LEU SER GLU SEQRES 8 B 147 LEU HIS CYS ASP LYS LEU HIS VAL ASP PRO GLU ASN PHE SEQRES 9 B 147 ARG LEU LEU GLY ASN VAL LEU VAL CYS VAL LEU ALA HIS SEQRES 10 B 147 HIS PHE GLY LYS GLU PHE THR PRO PRO VAL GLN ALA ALA SEQRES 11 B 147 TYR GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA SEQRES 12 B 147 HIS LYS TYR HIS SEQRES 1 C 142 MET VAL LEU SER PRO ALA ASP LYS THR ASN VAL LYS ALA SEQRES 2 C 142 ALA TRP GLY LYS VAL GLY ALA HIS ALA GLY GLU TYR GLY SEQRES 3 C 142 ALA GLU ALA LEU GLU ARG MET PHE LEU SER PHE PRO THR SEQRES 4 C 142 THR LYS THR TYR PHE PRO HIS PHE ASP LEU SER HIS GLY SEQRES 5 C 142 SER ALA GLN VAL LYS GLY HIS GLY LYS LYS VAL ALA ASP SEQRES 6 C 142 ALA LEU THR ASN ALA VAL ALA HIS VAL ASP ASP MET PRO SEQRES 7 C 142 ASN ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS SEQRES 8 C 142 LEU ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS SEQRES 9 C 142 CYS LEU LEU VAL THR LEU ALA ALA HIS LEU PRO ALA GLU SEQRES 10 C 142 PHE THR PRO ALA VAL HIS ALA SER LEU ASP LYS PHE LEU SEQRES 11 C 142 ALA SER VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 D 147 MET VAL HIS LEU THR PRO GLU GLU LYS SER ALA VAL THR SEQRES 2 D 147 ALA LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY SEQRES 3 D 147 GLU ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR SEQRES 4 D 147 GLN ARG PHE PHE GLU SER PHE GLY ASP LEU SER THR PRO SEQRES 5 D 147 ASP ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY SEQRES 6 D 147 LYS LYS VAL LEU GLY ALA PHE SER ASP GLY LEU ALA HIS SEQRES 7 D 147 LEU ASP ASN LEU LYS GLY THR PHE ALA THR LEU SER GLU SEQRES 8 D 147 LEU HIS CYS ASP LYS LEU HIS VAL ASP PRO GLU ASN PHE SEQRES 9 D 147 ARG LEU LEU GLY ASN VAL LEU VAL CYS VAL LEU ALA HIS SEQRES 10 D 147 HIS PHE GLY LYS GLU PHE THR PRO PRO VAL GLN ALA ALA SEQRES 11 D 147 TYR GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA SEQRES 12 D 147 HIS LYS TYR HIS HET HEM A 201 43 HET CMO A 202 2 HET N2Q A 203 11 HET HEM B 201 43 HET CMO B 202 2 HET HEM C 201 43 HET CMO C 202 2 HET N2Q C 203 11 HET HEM D 201 43 HET CMO D 202 2 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM CMO CARBON MONOXIDE HETNAM N2Q (5P)-5-(5-METHYLFURAN-2-YL)-1H-PYRAZOLE HETSYN HEM HEME FORMUL 5 HEM 4(C34 H32 FE N4 O4) FORMUL 6 CMO 4(C O) FORMUL 7 N2Q 2(C8 H8 N2 O) FORMUL 15 HOH *763(H2 O) HELIX 1 AA1 SER A 3 GLY A 15 1 13 HELIX 2 AA2 LYS A 16 ALA A 19 5 4 HELIX 3 AA3 HIS A 20 PHE A 36 1 17 HELIX 4 AA4 PRO A 37 PHE A 43 5 7 HELIX 5 AA5 SER A 52 HIS A 72 1 21 HELIX 6 AA6 ASP A 75 LEU A 80 1 6 HELIX 7 AA7 LEU A 80 ALA A 88 1 9 HELIX 8 AA8 ASP A 94 LEU A 113 1 20 HELIX 9 AA9 THR A 118 THR A 137 1 20 HELIX 10 AB1 THR B 4 LYS B 17 1 14 HELIX 11 AB2 GLU B 22 TYR B 35 1 14 HELIX 12 AB3 PRO B 36 GLY B 46 5 11 HELIX 13 AB4 THR B 50 ASN B 57 1 8 HELIX 14 AB5 ASN B 57 ALA B 76 1 20 HELIX 15 AB6 HIS B 77 ASP B 79 5 3 HELIX 16 AB7 ASN B 80 PHE B 85 1 6 HELIX 17 AB8 PHE B 85 ASP B 94 1 10 HELIX 18 AB9 ASP B 99 GLY B 119 1 21 HELIX 19 AC1 LYS B 120 PHE B 122 5 3 HELIX 20 AC2 THR B 123 ALA B 142 1 20 HELIX 21 AC3 HIS B 143 HIS B 146 5 4 HELIX 22 AC4 SER C 3 LYS C 16 1 14 HELIX 23 AC5 VAL C 17 ALA C 19 5 3 HELIX 24 AC6 HIS C 20 PHE C 36 1 17 HELIX 25 AC7 PRO C 37 PHE C 43 5 7 HELIX 26 AC8 SER C 52 HIS C 72 1 21 HELIX 27 AC9 ASP C 75 LEU C 80 1 6 HELIX 28 AD1 LEU C 80 HIS C 89 1 10 HELIX 29 AD2 ASP C 94 LEU C 113 1 20 HELIX 30 AD3 THR C 118 SER C 138 1 21 HELIX 31 AD4 THR D 4 GLY D 16 1 13 HELIX 32 AD5 GLU D 22 TYR D 35 1 14 HELIX 33 AD6 PRO D 36 GLY D 46 5 11 HELIX 34 AD7 THR D 50 ASN D 57 1 8 HELIX 35 AD8 ASN D 57 ALA D 76 1 20 HELIX 36 AD9 ASN D 80 PHE D 85 1 6 HELIX 37 AE1 PHE D 85 ASP D 94 1 10 HELIX 38 AE2 ASP D 99 GLY D 119 1 21 HELIX 39 AE3 LYS D 120 PHE D 122 5 3 HELIX 40 AE4 THR D 123 ALA D 142 1 20 HELIX 41 AE5 HIS D 143 HIS D 146 5 4 LINK N VAL A 1 C11 N2Q A 203 1555 1555 1.30 LINK N VAL C 1 C11 N2Q C 203 1555 1555 1.35 LINK NE2 HIS A 87 FE HEM A 201 1555 1555 2.04 LINK NE2 HIS B 92 FE HEM B 201 1555 1555 2.03 LINK NE2 HIS C 87 FE HEM C 201 1555 1555 2.05 LINK NE2 HIS D 92 FE HEM D 201 1555 1555 2.04 CRYST1 62.614 83.120 105.122 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015971 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012031 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009513 0.00000